𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of adjuvant agents in treating fungal diseases

✍ Scribed by Shellee A. Grim; Nina M. Clark

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
329 KB
Volume
3
Category
Article
ISSN
1936-3761

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The role of gabapentin in treating disea
The role of gabapentin in treating diseases with cutaneous manifestations and pain
✍ Noah Scheinfeld πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract **Background** Gabapentin was first approved by the FDA in 1993 as an add‐on treatment for partial epileptic seizures. In May of 2002, it was approved as treatment for post‐herpetic neuralgia by the Food and Drug Adminstration. It appears to be a promising agent in the treatment of pain

The inhibition of adjuvant disease in ra
The inhibition of adjuvant disease in rats by the interferon-inducing agent pyran copolymer
✍ By M. A. Kapusta; J. Mendelson πŸ“‚ Article πŸ“… 1969 πŸ› John Wiley and Sons 🌐 English βš– 643 KB

The effect of pyran copolymer, a synthetic polyanionic interferon inducer, was studied in adjuvant-induced disease in rats. This agent was shown to induce interferon in Sprague-Dawley and CD@F rats and to inhibit adjuvant-induced arthritis in both species of rats. Splenomegaly was inhibited in CD@F

The role of hsp90 in fungal infection
The role of hsp90 in fungal infection
✍ Ruth Matthews; James Burnie πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier Science 🌐 English βš– 473 KB